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Definition and causes of wheeze 
Prevalence studies of recurrent wheeze in children 
under five have reported that one third of children 
in the US and Europe are affected, and rates and 
severity appear to be higher in developing 
countries.1,2  
Episodic cough and wheezing is common in non-
asthmatic children. Young children with multiple-
trigger wheeze are more likely to have asthma 
compared to those with episodic (viral) wheeze. 
Atopic features, family history, and association 
between wheeze and colds or other triggers such as 
cigarette smoke, allergens, and exercise help 
predicting asthma.3  
 
Table 1. Definition of wheezing disorders in preschool children. 
 
 
Adapted from Brand, et al. Eur Respir J 2008;32:1096-110.4 
 
The role of airway infections 
Upper respiratory tract infections account for more 
than 80% of wheezing episodes in young children. 
Most children wheeze only when they have 
respiratory tract infections, are usually non-atopic, 
and outgrow symptoms by 6 years of age. Yet, 
since preschool-age children have 6 to 10 upper 
respiratory tract infections each year, recurrent 
virus-induced wheezing is associated with 
considerable distress and use of health care 
services.5 
Many infants with severe bronchiolitis 
experience recurrent wheezing in later childhood.6 
Acute bronchiolitis is usually caused by: 
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• Respiratory syncytial virus (RSV) which infects 
most children worldwide by the age of two years 
• Rhinovirus 
• Human metapneumovirus (hMPV)  
• Parainfluenza virus  
• Influenza virus  
• Adenovirus   
 
Rhinoviruses (RVs) and recurrent wheeze 
The mean age at the first symptomatic RV infection 
is 4 - 6 months compared with more than 6 months 
for other viruses, such as RSV. Re-infections occur 
regularly and are usually caused by different viral 
strains. RVs are frequently associated with wheeze 
in infants aged from 2–6 months. Whether RV 
infections are directly involved in the development 
of wheeze or whether they unveil obstructive lung 
diseases, is subject to debate. As RVs have the 
ability to invade lower airways and escape 
immunity, they may promote exaggerated 
inflammatory responses towards further stimuli, 
such as allergens, and lead to enhanced airway 
responsiveness. Infancy is a period of profound 
growth and development for the pulmonary and 
immune systems, and recurrent RV infections and 
associated inflammatory and remodeling processes 
may thus disrupt normal processes of lung growth.7 
 
Human Metapneumovirus (hMPV) and recurrent 
wheeze 
hMPV has a worldwide distribution and affects all 
age groups but predominantly affects young, elderly 
and immunocompromised patients, with children 
younger than five years of age being most 
susceptible to infection. Infection with hMPV 
occurs throughout the year but seasonal prevalence 
in late winter and spring has been observed and 
coincides with the peak of RSV infection.8 In a 
large, prospective study of children with lower 
respiratory tract illness, human metapneumovirus 
was identified in 49 of 248 specimens (20 percent) 
that were negative for other pathogenic viruses The 
mean age of the infected children was 11.6 months, 
and 59 percent had symptoms of bronchiolitis.9 
 
The role of bacterial colonization 
Colonization of the airways with S. pneumoniae, H. 
influenzae, M. catarrhalis, or more than one of these 
organisms in asymptomatic neonates at one month 
of age was associated with increases by a factor of 
two to four in the risk of a first wheezy episode, 
persistent wheeze, acute severe exacerbation of 
wheeze, and hospitalization for wheeze, as well as 
increased blood eosinophil counts and total IgE 
and, eventually, increased reversibility of airway 
resistance and development of asthma by the age of 
5 years. These associations are compatible with the 
observation of a predominantly neutrophilic 
inflammation in young children with severe 
recurrent wheeze.10 
 
Early life Anatomic Features of the Airways 
Until approximately 18 months of age, infants are 
virtually obligatory nose breathers. The airway 
caliber is considerably smaller than in older 
children and adults. If the radius of an airway is 
reduced, resistance will increase. As a consequence, 
factors that limit ventilation may be magnified in 
infants compared with older children and adults. 
The infant larynx is situated much higher in the 
upper respiratory tract (URT), close to the base of 
the tongue, and the epiglottis, which is relatively 
narrow and floppy, is located closer to the palate. 
The infant pharynx and supraglottic tissues are less 
rigid than those of adults and thus more susceptible 
to collapse and obstruction of the URT, particularly 
during inspiration. These anatomic differences 
could partially explain the infant preference for 
nose breathing and the difficulty of delivery of 
therapeutic aerosols to the lower respiratory tract 
(LRT).11 
 
Gender differences in lung growth and development 
Although girls tend to have smaller lungs and fewer 
bronchioles than boys in early childhood, they have 
higher size-corrected flow rates and specific airway 
conductance, probably due to a higher ratio of large 
to small airways. In addition, surfactant production, 
which begins at about 30 weeks’ gestation, is 
delayed in males, possibly because of androgen 
production. Enhanced surfactant production in 
females might lead to increased patency of the 
small airways, and this could reduce the risk of 
respiratory distress in the neonatal period and 
possibly reduce the risk for virus-induced wheeze in 
early infancy.12 
 
Functional features of the airways of recurrent 
wheezers 
Compared with healthy controls, airway function is 
reduced in young children with recurrent wheeze, 
particularly those at risk for subsequent asthma. 
After adjustment for sex, age, body length and 
maternal smoking, significant reductions in 
expiratory flows and volumes were observed in 
steroid naïve young children with three or more 
episodes of physician confirmed wheeze.13 
 
 
Pathology of the airways in preschool wheeze 
5 
Disturbed lung functions in young wheezers 
It was hypothesized that younger children may have 
relatively small airways caliber, significantly 
limiting airflow, and thus impairing secretion 
clearance and predisposing to lower airway 
infection. Elevated functional reserve capacity 
(FRC) was associated with anatomical lower airway 
abnormalities. The forced vital capacity (FVC) was 
higher in subjects with neutrophilic inflammation.14 
 
Airway remodeling in preschool children with 
severe recurrent wheeze 
In a study using flexible endoscopy, reticular 
basement membrane thickness was lower in 
preschool recurrent wheezers than in school 
children with asthma and was lowest below three 
years of age. Airway smooth muscle area was lower 
in preschoolers than in school children and was 
highest in preschoolers with atopy. Vascularity was 
higher in wheezy children under three years than in 
those 3-5 years old or school aged asthmatics. 
Mucus gland area was higher in preschoolers than 
in school children. Inflammatory cell counts in 
biopsies did not correlate with airway wall 
structure.15 
 
The malfunction of alveolar macrophages in young 
infants  
In the mature lung, alveolar macrophages (AM) 
prevent inappropriate immune activation by 
removing inhaled antigen via phagocytosis, and by 
directly suppressing pulmonary T cell proliferation. 
AM suppression of T cell proliferation is attenuated 
during the critical period for the development of 
immune tolerance, i.e. the first few months of life. 
Compared with the older child, there is attenuation 
of suppression of peripheral blood mononuclear 
cells (PBMC) proliferation in the infant at the 
higher AM:PBMC ratios.16 
 
Vitamin D Status and Recurrent Wheeze 
Vitamin D may modulate the risk of wheezing 
exacerbations being inversely associated with 
adverse asthma-related outcomes in older children 
and adolescents. The situation in infants and young 
children is less clear. A higher rate of exacerbation 
requiring oral corticosteroids (OCS) was observed 
in preschool children with severe intermittent 
wheezing who had serum 25-OH-VitD levels <20 
ng/ml.17 
The observed inverse associations between 
25(OH)D levels and specific types of viral infection 
raise the question of whether vitamin D could 
moderate the frequency or severity of acute 
respiratory tract infections.18 A strong inverse 
association between maternal intake of vitamin D 
during pregnancy and risk of recurrent wheeze in 
children at 3 y of age was reported. Pregnant and 
lactating women are known to be at higher risk of 
vitamin D deficiency, and this observation provides 
additional support to the recommendations of 
maternal intake of >400 IU/d during pregnancy.19 
However, a more recent study revealed that the 
use of 2800 IU/d of vitamin D3 during the third 
trimester of pregnancy compared with 400 IU/d did 
not result in a statistically significant reduced risk 
of persistent wheeze in the offspring through age 3 
years.20 Also, the 2017 Global Initiative for Asthma 
(GINA) guidelines stated that there is no good 
quality evidence to date that vitamin D 
supplementation leads to improved asthma control 
or fewer exacerbations.21 
 
Key Notes 
• Viral respiratory infection is the leading cause 
wheezing episodes in infants and young children 
• Bacterial colonization of the airway in early 
infancy may increase the risk of recurrent wheeze 
• Upper and lower airway anatomic peculiarities in 
infants and young children contribute to airway 
resistance 
• Airway remodeling can start in young children 
• The relation between nutritional status and the 
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